Agios Pharmaceuticals Inc

NASDAQ:AGIO  
44.68
-0.98 (-2.15%)
Products

Agios Reports FDA Orphan Drug Designation Granted To Mitapivat

Published: 11/12/2020 22:05 GMT
Agios Pharmaceuticals Inc (AGIO) - Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease.